Science Explorer Interactive view Map
Company · Planegg · Germany

Hikma Pharmaceuticals (Germany)

hikma.com/en/index.htmlROR OpenAlex
Research works
16
▲ 1857% vs 2013–17
Citations
275
16.8 per fractional work
Top-10% rate
6.4%
record average 16.5%
Open access
45%
world 28%

Not ranked overall: Hikma Pharmaceuticals (Germany) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Which research topics does Hikma Pharmaceuticals (Germany) publish most on?

By volume in 2022–2025: Angiogenesis and VEGF in Cancer, Cancer, Hypoxia, and Metabolism, Immune Response and Inflammation and Immunotherapy and Immune Responses.

Angiogenesis and VEGF in…2Angiogenesis and VEGF in Cancer: 2 fractional worksCancer, Hypoxia, and Met…1Cancer, Hypoxia, and Metabolism: 1 fractional worksImmune Response and Inflammation: 0 fractional worksImmunotherapy and Immune Responses: 0 fractional worksCancer Research and Trea…0Cancer Research and Treatments: 0 fractional worksRNA Interference and Gene Delivery: 0 fractional worksCancer Cells and Metastasis: 0 fractional worksSingle-cell and spatial transcriptomics: 0 fractional worksCancer-related molecular mechanisms research: 0 fractional worksLipid metabolism and disorders: 0 fractional works
Molecular BiologyCancer ResearchImmunologyBiotechnology2 others

Area is fractional works; colour is the subfield each topic belongs to.

  1. 1 Angiogenesis and VEGF in Cancer Molecular Biology 2 works
  2. 2 Cancer, Hypoxia, and Metabolism Cancer Research 1 works
  3. 3 Immune Response and Inflammation Immunology 0 works
  4. 4 Immunotherapy and Immune Responses Immunology 0 works
  5. 5 Cancer Research and Treatments Biotechnology 0 works
  6. 6 RNA Interference and Gene Delivery Molecular Biology 0 works
  7. 7 Cancer Cells and Metastasis Oncology 0 works
  8. 8 Single-cell and spatial transcriptomics Molecular Biology 0 works
  9. 9 Cancer-related molecular mechanisms research Cancer Research 0 works
  10. 10 Lipid metabolism and disorders Cardiology and Cardiovascular Medicine 0 works

How open and international is its research?

Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available45.3%not open54.7%

World: 28% of research is openly available.

with international co-authors58.7%domestic only41.3%

World: 19% is written across borders.

How has Hikma Pharmaceuticals (Germany)'s research output changed?

Output in 2018–2022 was 1857% higher than in 2013–2017.

2005201020152020
grewheldshrank

The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.

Other research institutions in Planegg

All research institutions in Planegg

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.